The National Myelodysplastic Syndromes Natural History Study

What is the purpose of this trial?

Multi-center study enrolling patients suspected or newly diagnosed with myelodysplastic syndromes (MDS), myelodysplastic syndromes/myeloproliferative neoplasms (MDS/MPN) overlap disorder, or idiopathic cytopenia of undetermined significance (ICUS). Participants will be followed long term. Clinical data, blood, and tissue samples will be collected to establish a biorepository to facilitate the study of the natural history of MDS.

Participation Guidelines

Ages: 18 years and older

Gender: Both

Eastern Cooperative Oncology Group

Start Date: 12/12/2017

End Date: 09/01/2021

Last Updated: 02/22/2018

Study HIC#: 1607018080